414 related articles for article (PubMed ID: 26261690)
1. Transarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patients.
Facciorusso A; Licinio R; Muscatiello N; Di Leo A; Barone M
World J Hepatol; 2015 Aug; 7(16):2009-19. PubMed ID: 26261690
[TBL] [Abstract][Full Text] [Related]
2. Drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma: Current state of the art.
Facciorusso A
World J Gastroenterol; 2018 Jan; 24(2):161-169. PubMed ID: 29375202
[TBL] [Abstract][Full Text] [Related]
3. Conventional
Song JE; Kim DY
World J Hepatol; 2017 Jun; 9(18):808-814. PubMed ID: 28706579
[TBL] [Abstract][Full Text] [Related]
4. Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence.
Raoul JL; Forner A; Bolondi L; Cheung TT; Kloeckner R; de Baere T
Cancer Treat Rev; 2019 Jan; 72():28-36. PubMed ID: 30447470
[TBL] [Abstract][Full Text] [Related]
5. [Survival benefit with intraarterial techniques in hepatocellular carcinoma].
Sangro B
Gastroenterol Hepatol; 2014 Jul; 37 Suppl 2():95-101. PubMed ID: 25087719
[TBL] [Abstract][Full Text] [Related]
6. Conventional transarterial chemoembolization versus drug-eluting bead transarterial chemoembolization for the treatment of hepatocellular carcinoma.
Kloeckner R; Weinmann A; Prinz F; Pinto dos Santos D; Ruckes C; Dueber C; Pitton MB
BMC Cancer; 2015 Jun; 15():465. PubMed ID: 26059447
[TBL] [Abstract][Full Text] [Related]
7. Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system.
Han K; Kim JH
World J Gastroenterol; 2015 Sep; 21(36):10327-35. PubMed ID: 26420959
[TBL] [Abstract][Full Text] [Related]
8. Transarterial chemoembolization (TACE) for unresectable HCC: a new life begins?
Biolato M; Marrone G; Racco S; Di Stasi C; Miele L; Gasbarrini G; Landolfi R; Grieco A
Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):356-62. PubMed ID: 20496548
[TBL] [Abstract][Full Text] [Related]
9. Comparison of lipiodol infusion and drug-eluting beads transarterial chemoembolization of hepatocellular carcinoma in a real-life setting.
Karalli A; Teiler J; Haji M; Seth E; Brismar TB; Wahlin S; Axelsson R; Stål P
Scand J Gastroenterol; 2019 Jul; 54(7):905-912. PubMed ID: 31287338
[No Abstract] [Full Text] [Related]
10. Transarterial chemoembolization with drug-eluting beads in hepatocellular carcinoma.
Nam HC; Jang B; Song MJ
World J Gastroenterol; 2016 Oct; 22(40):8853-8861. PubMed ID: 27833376
[TBL] [Abstract][Full Text] [Related]
11. CalliSpheres drug-eluting beads versus lipiodol transarterial chemoembolization in the treatment of hepatocellular carcinoma: a short-term efficacy and safety study.
Wu B; Zhou J; Ling G; Zhu D; Long Q
World J Surg Oncol; 2018 Mar; 16(1):69. PubMed ID: 29587773
[TBL] [Abstract][Full Text] [Related]
12. Transarterial chemoembolization in hepatocellular carcinoma with vascular invasion or extrahepatic metastasis: A systematic review.
Zhao Y; Cai G; Zhou L; Liu L; Qi X; Bai M; Li Y; Fan D; Han G
Asia Pac J Clin Oncol; 2013 Dec; 9(4):357-64. PubMed ID: 23714021
[TBL] [Abstract][Full Text] [Related]
13. New concepts in embolotherapy of HCC.
Pesapane F; Nezami N; Patella F; Geschwind JF
Med Oncol; 2017 Apr; 34(4):58. PubMed ID: 28299645
[TBL] [Abstract][Full Text] [Related]
14. Transarterial chemoembolization for hepatocellular carcinoma: an evidence-based review of its place in therapy.
Jang JH; Lee JW; Hong JT; Jin YJ
J Hepatocell Carcinoma; 2015; 2():123-9. PubMed ID: 27508201
[TBL] [Abstract][Full Text] [Related]
15. Conventional Versus Small Doxorubicin-eluting Bead Transcatheter Arterial Chemoembolization for Treating Barcelona Clinic Liver Cancer Stage 0/A Hepatocellular Carcinoma.
Kang YJ; Lee BC; Kim JK; Yim NY; Kim HO; Cho SB; Jeong YY
Cardiovasc Intervent Radiol; 2020 Jan; 43(1):55-64. PubMed ID: 31646378
[TBL] [Abstract][Full Text] [Related]
16. Transcatheter embolization therapy in liver cancer: an update of clinical evidences.
Wáng YX; De Baere T; Idée JM; Ballet S
Chin J Cancer Res; 2015 Apr; 27(2):96-121. PubMed ID: 25937772
[TBL] [Abstract][Full Text] [Related]
17. Therapy of Intermediate-Stage Hepatocellular Carcinoma: Current Evidence and Clinical Practice.
Chai NX; Chapiro J
Semin Intervent Radiol; 2020 Dec; 37(5):456-465. PubMed ID: 33328701
[TBL] [Abstract][Full Text] [Related]
18. Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future.
Woo HY; Heo J
Clin Mol Hepatol; 2015 Dec; 21(4):344-8. PubMed ID: 26770921
[TBL] [Abstract][Full Text] [Related]
19. Transarterial chemoembolization with drug-eluting beads versus conventional transarterial chemoembolization in locally advanced hepatocellular carcinoma.
Baur J; Ritter CO; Germer CT; Klein I; Kickuth R; Steger U
Hepat Med; 2016; 8():69-74. PubMed ID: 27382341
[TBL] [Abstract][Full Text] [Related]
20. Is Transarterial Chemoembolization Only Treatment Option in Patients with Intermediate Stage of Hepatocellular Carcinoma?: in Perspectives of Surgery.
Lim JY; Lee M; Kim TH
J Liver Cancer; 2020 Sep; 20(2):113-119. PubMed ID: 37384321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]